La Chandra Pharmalab Pvt Ltd
Ahmedabad, India
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: La Chandra Pharmalab Pvt Ltd
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Ahmedabad, India
- Modalities
- Hormone API (Progesterone, Estradiol Hemihydrate, Norethisterone, Norethisterone Acetate, Mifepristone, Dydrogesterone, Hydroxyprogesterone Caproate, Medroxyprogesterone Acetate), Niche Active Pharmaceutical Ingredients (APIs), Pharmaceutical Quality Control Services, Process R&D (API)
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About La Chandra Pharmalab Pvt Ltd
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesHormone API (Progesterone, Estradiol Hemihydrate, Norethisterone, Norethisterone Acetate, Mifepristone, Dydrogesterone, Hydroxyprogesterone Caproate, Medroxyprogesterone Acetate), Niche Active Pharmaceutical Ingredients (APIs), Pharmaceutical Quality Control Services, Process R&D (API)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (4 modalities)
Frequently Asked Questions About La Chandra Pharmalab Pvt Ltd
What is La Chandra Pharmalab Pvt Ltd's CDMO Signal Score?
La Chandra Pharmalab Pvt Ltd has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating La Chandra Pharmalab Pvt Ltd for a manufacturing program?
Use the free AI matchmaker to compare La Chandra Pharmalab Pvt Ltd against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.